Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Journal of Pharmacokinetics and Pharmacodynamics|October 4, 2002
Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysisRichard R Almon, Debra C DuBois, Emily H Brandenburg, et al.Journal of Proteome Research|March 29, 2016
Large-Scale, Ion-Current-Based Proteomic Investigation of the Rat Striatal Proteome in a Model of Short- and Long-Term Cocaine WithdrawalShichen Shen, Xiaosheng Jiang, Jun Li, et al.Journal of Proteome Research|March 18, 2009
A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteomeXiaotao Duan, Rebeccah Young, Robert M Straubinger, et al.Journal of Pharmaceutical Sciences|November 2, 2023
Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis PathwaysXin Miao, Gilbert Koch, Shichen Shen, et al.Acta Biomaterialia|August 25, 2022
Formation of hydrated PEG layers on magnetic iron oxide nanoflowers shows internal magnetisation dynamics and generates high in-vivo efficacy for MRI and magnetic hyperthermiaEoin P McKiernan, Cara Moloney, Tista Roy Chaudhuri, et al.Journal of Pharmaceutical Sciences|March 18, 2024
Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part I: Effects on Signal Transduction Pathways Related to Tumor GrowthXin Miao, Shichen Shen, Gilbert Koch, et al.British Journal of Pharmacology|November 23, 2023
Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancerQingxiang Lin, Andrea Serratore, Jonathan Perri, et al.Cancer Chemotherapy and Pharmacology|March 5, 2013
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in miceDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.Proteomics. Clinical Applications|December 13, 2016
Quantitative proteomic profiling of paired cancerous and normal colon epithelial cells isolated freshly from colorectal cancer patientsChengjian Tu, Wilfrido Mojica, Robert M Straubinger, et al.Cancer Chemotherapy and Pharmacology|March 5, 2013
Physiologically based pharmacokinetic models for everolimus and sorafenib in miceDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.Pageof 9